Oyerinde Rebecca Opeyemi, Risenga Ida Masana
School of Animal, Plant and Environmental Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Chem Biodivers. 2025 Jun;22(6):e202403198. doi: 10.1002/cbdv.202403198. Epub 2025 Feb 26.
Tulbaghia violacea is an established medicinal plant that is indigenous to southern Africa. All its plant parts have been profiled for their phytochemical constituents and medicinal potentials except for the seeds and fruits. Thus, this study assessed the seeds (air-dried) and fruits (freeze-dried), extracted with six solvents, for their bioactive compounds, antioxidant capacities, and antibacterial activities. All the 10 tested phytochemicals were detected across the six solvents, with more phytochemicals detected in the fruits. The fruit aqueous extract gave the highest yield (37.4%), while the hexanoic fruit extract had the lowest extraction yield (3.27%). The fruit had higher phenolic content across the solvents except in methanol. Conversely, except in hexanoic extracts, the seed had higher total proanthocyanidin contents across the solvents. In addition, the fruit had a higher total antioxidant capacity than the seeds, similar to the observation in the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay. T. violacea fruit and seeds showed antibacterial activity against Escherichia coli, Staphylococcus aureus, and Enterococcus faecalis, but this activity was dose-dependent. However, neither the fruit nor the seed extract had any antibacterial effect on Klebsiella pneumoniae. This study showed that T. violacea fruits and seeds may be additional resources with medicinal benefits for human use.
紫花郁金香是一种原产于南部非洲的知名药用植物。除种子和果实外,其所有植物部位的植物化学成分和药用潜力均已得到分析。因此,本研究对用六种溶剂提取的种子(风干)和果实(冻干)进行了生物活性化合物、抗氧化能力和抗菌活性的评估。在六种溶剂中均检测到了所有10种被测植物化学成分,果实中检测到的植物化学成分更多。果实水提取物的得率最高(37.4%),而己酸果实提取物的提取率最低(3.27%)。除甲醇外,果实中各溶剂的酚类含量均较高。相反,除己酸提取物外,种子中各溶剂的原花青素总含量较高。此外,果实的总抗氧化能力高于种子,这与1,1-二苯基-2-苦基肼(DPPH)测定中的观察结果相似。紫花郁金香果实和种子对大肠杆菌、金黄色葡萄球菌和粪肠球菌具有抗菌活性,但这种活性具有剂量依赖性。然而,果实提取物和种子提取物对肺炎克雷伯菌均无抗菌作用。本研究表明,紫花郁金香果实和种子可能是对人类具有药用价值的额外资源。